1
|
Schmid F, Henry A, Benzerouk F, Barrière S, Portefaix C, Gondrexon J, Obert A, Kaladjian A, Gierski F. Neural activations during cognitive and affective theory of mind processing in healthy adults with a family history of alcohol use disorder. Psychol Med 2024; 54:1034-1044. [PMID: 37753626 DOI: 10.1017/s0033291723002854] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/28/2023]
Abstract
BACKGROUND Social cognition impairments are a common feature of alcohol use disorders (AUD). However, it remains unclear whether these impairments are solely the consequence of chronic alcohol consumption or whether they could be a marker of vulnerability. METHODS The present study implemented a family history approach to address this question for a key process of social cognition: theory of mind (ToM). Thirty healthy adults with a family history of AUD (FH+) and 30 healthy adults with a negative family history of AUD (FH-), matched for age, sex, and education level, underwent an fMRI cartoon-vignette paradigm assessing cognitive and affective ToM. Participants also completed questionnaires evaluating anxiety, depressive symptoms, childhood trauma, and alexithymia. RESULTS Results indicated that FH+ individuals differed from FH- individuals on affective but not cognitive ToM processing, at both the behavioral and neural levels. At the behavioral level, the FH+ group had lower response accuracy for affective ToM compared with the FH- group. At the neural level, the FH+ group had higher brain activations in the left insula and inferior frontal cortex during affective ToM processing. These activations remained significant when controlling for depressive symptoms, anxiety, and childhood trauma. CONCLUSIONS These findings highlight difficulties during affective ToM processing among first-degree relatives of AUD patients, supporting the idea that some of the impairments exhibited by these patients may already be present before the onset of AUD and may be considered a marker of vulnerability.
Collapse
Affiliation(s)
- F Schmid
- Laboratoire Cognition, Santé, Société (C2S - EA 6291), University of Reims Champagne-Ardenne, Reims, France
| | - A Henry
- Laboratoire Cognition, Santé, Société (C2S - EA 6291), University of Reims Champagne-Ardenne, Reims, France
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
| | - F Benzerouk
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
- INSERM U1247, Research Group on Alcohol and Dependences, University of Picardy Jules Verne, Amiens, France
| | - S Barrière
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
| | - C Portefaix
- Radiology Department, Maison Blanche Hospital, Reims University Hospital, Reims, France
- Centre de Recherche en Sciences et Technologies de l'Information et de la Communication (CReSTIC - EA 3804), University of Reims Champagne-Ardenne, Reims, France
| | - J Gondrexon
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
| | - A Obert
- Laboratoire Sciences de la Cognition, Technologie, Ergonomie (SCOTE - EA 7420), Champollion National University Institute, Albi, France
| | - A Kaladjian
- Laboratoire Cognition, Santé, Société (C2S - EA 6291), University of Reims Champagne-Ardenne, Reims, France
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
| | - F Gierski
- Laboratoire Cognition, Santé, Société (C2S - EA 6291), University of Reims Champagne-Ardenne, Reims, France
- Psychiatry Department, Marne Public Mental Health Institute & Reims University Hospital, Reims, France
- INSERM U1247, Research Group on Alcohol and Dependences, University of Picardy Jules Verne, Amiens, France
| |
Collapse
|
2
|
Gentry AE, Alexander JC, Ahangari M, Peterson RE, Miles MF, Bettinger JC, Davies AG, Groteweil M, Bacanu SA, Kendler KS, Riley BP, Webb BT. Case-only exome variation analysis of severe alcohol dependence using a multivariate hierarchical gene clustering approach. PLoS One 2023; 18:e0283985. [PMID: 37098020 PMCID: PMC10128939 DOI: 10.1371/journal.pone.0283985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2022] [Accepted: 03/21/2023] [Indexed: 04/26/2023] Open
Abstract
BACKGROUND Variation in genes involved in ethanol metabolism has been shown to influence risk for alcohol dependence (AD) including protective loss of function alleles in ethanol metabolizing genes. We therefore hypothesized that people with severe AD would exhibit different patterns of rare functional variation in genes with strong prior evidence for influencing ethanol metabolism and response when compared to genes not meeting these criteria. OBJECTIVE Leverage a novel case only design and Whole Exome Sequencing (WES) of severe AD cases from the island of Ireland to quantify differences in functional variation between genes associated with ethanol metabolism and/or response and their matched control genes. METHODS First, three sets of ethanol related genes were identified including those a) involved in alcohol metabolism in humans b) showing altered expression in mouse brain after alcohol exposure, and altering ethanol behavioral responses in invertebrate models. These genes of interest (GOI) sets were matched to control gene sets using multivariate hierarchical clustering of gene-level summary features from gnomAD. Using WES data from 190 individuals with severe AD, GOI were compared to matched control genes using logistic regression to detect aggregate differences in abundance of loss of function, missense, and synonymous variants, respectively. RESULTS Three non-independent sets of 10, 117, and 359 genes were queried against control gene sets of 139, 1522, and 3360 matched genes, respectively. Significant differences were not detected in the number of functional variants in the primary set of ethanol-metabolizing genes. In both the mouse expression and invertebrate sets, we observed an increased number of synonymous variants in GOI over matched control genes. Post-hoc simulations showed the estimated effects sizes observed are unlikely to be under-estimated. CONCLUSION The proposed method demonstrates a computationally viable and statistically appropriate approach for genetic analysis of case-only data for hypothesized gene sets supported by empirical evidence.
Collapse
Affiliation(s)
- Amanda Elswick Gentry
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Jeffry C. Alexander
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Mohammad Ahangari
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Integrative Life Sciences Ph.D. Program, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Roseann E. Peterson
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry and Behavioral Sciences, Institute for Genomics in Health, SUNY Downstate Health Sciences University, Brooklyn, New York, United States of America
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Michael F. Miles
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Jill C. Bettinger
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Andrew G. Davies
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Mike Groteweil
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Silviu A. Bacanu
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Kenneth S. Kendler
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Brien P. Riley
- Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia, United States of America
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia, United States of America
| | - Bradley T. Webb
- VCU Alcohol Research Center, Virginia Commonwealth University, Richmond, Virginia, United States of America
- GenOmics, Bioinformatics, and Translational Research Center, Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, North Caroline, United States of America
| | | |
Collapse
|
3
|
Pandey G, Seay MJ, Meyers JL, Chorlian DB, Pandey AK, Kamarajan C, Ehrenberg M, Pitti D, Kinreich S, Subbie-Saenz de Viteri S, Acion L, Anokhin A, Bauer L, Chan G, Edenberg H, Hesselbrock V, Kuperman S, McCutcheon VV, Bucholz KK, Schuckit M, Porjesz B. Density and Dichotomous Family History Measures of Alcohol Use Disorder as Predictors of Behavioral and Neural Phenotypes: A Comparative Study Across Gender and Race/Ethnicity. Alcohol Clin Exp Res 2020; 44:697-710. [PMID: 31957047 PMCID: PMC8357185 DOI: 10.1111/acer.14280] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Accepted: 12/22/2019] [Indexed: 11/28/2022]
Abstract
BACKGROUND Family history (FH) is an important risk factor for the development of alcohol use disorder (AUD). A variety of dichotomous and density measures of FH have been used to predict alcohol outcomes; yet, a systematic comparison of these FH measures is lacking. We compared 4 density and 4 commonly used dichotomous FH measures and examined variations by gender and race/ethnicity in their associations with age of onset of regular drinking, parietal P3 amplitude to visual target, and likelihood of developing AUD. METHODS Data from the Collaborative Study on the Genetics of Alcoholism (COGA) were utilized to compute the density and dichotomous measures. Only subjects and their family members with DSM-5 AUD diagnostic information obtained through direct interviews using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) were included in the study. Area under receiver operating characteristic curves were used to compare the diagnostic accuracy of FH measures at classifying DSM-5 AUD diagnosis. Logistic and linear regression models were used to examine associations of FH measures with alcohol outcomes. RESULTS Density measures had greater diagnostic accuracy at classifying AUD diagnosis, whereas dichotomous measures presented diagnostic accuracy closer to random chance. Both dichotomous and density measures were significantly associated with likelihood of AUD, early onset of regular drinking, and low parietal P3 amplitude, but density measures presented consistently more robust associations. Further, variations in these associations were observed such that among males (vs. females) and Whites (vs. Blacks), associations of alcohol outcomes with density (vs. dichotomous) measures were greater in magnitude. CONCLUSIONS Density (vs. dichotomous) measures seem to present more robust associations with alcohol outcomes. However, associations of dichotomous and density FH measures with different alcohol outcomes (behavioral vs. neural) varied across gender and race/ethnicity. These findings have great applicability for alcohol research examining FH of AUD.
Collapse
Affiliation(s)
- Gayathri Pandey
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Michael J Seay
- Department of Psychology, (MJS), University of California, Los Angeles, California
| | - Jacquelyn L Meyers
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - David B Chorlian
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Ashwini K Pandey
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Chella Kamarajan
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Morton Ehrenberg
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Daniel Pitti
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Sivan Kinreich
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Stacey Subbie-Saenz de Viteri
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| | - Laura Acion
- Iowa Consortium for Substance Abuse Research and Evaluation, (LA), University of Iowa, Iowa City, Iowa
| | - Andrey Anokhin
- Department of Psychiatry, (AA, VVM, KKB), Washington University School of Medicine in St. Louis, St. Louis, Missouri
| | - Lance Bauer
- Department of Psychiatry, (LB, GC, VH), University of Connecticut School of Medicine, Farmington, Connecticut
| | - Grace Chan
- Department of Psychiatry, (LB, GC, VH), University of Connecticut School of Medicine, Farmington, Connecticut
| | - Howard Edenberg
- Department of Biochemistry and Molecular Biology, (HE), Indiana University School of Medicine, Indianapolis, Indiana
| | - Victor Hesselbrock
- Department of Psychiatry, (LB, GC, VH), University of Connecticut School of Medicine, Farmington, Connecticut
| | - Samuel Kuperman
- Department of Psychiatry, (S Kuperman), University of Iowa Carver College of Medicine, Iowa City, Iowa
| | - Vivia V McCutcheon
- Department of Psychiatry, (AA, VVM, KKB), Washington University School of Medicine in St. Louis, St. Louis, Missouri
| | - Kathleen K Bucholz
- Department of Psychiatry, (AA, VVM, KKB), Washington University School of Medicine in St. Louis, St. Louis, Missouri
| | - Marc Schuckit
- Department of Psychiatry, (MS), University of California San Diego, La Jolla, California
| | - Bernice Porjesz
- From the, Department of Psychiatry and Behavioral Sciences, (GP, JLM, DBC, AKP, CK, ME, DP, S Kinreich, SS-SV, BP), Downstate Medical Center, State University of New York, Brooklyn, New York
| |
Collapse
|
4
|
Farris SP, Riley BP, Williams RW, Mulligan MK, Miles MF, Lopez MF, Hitzemann R, Iancu OD, Colville A, Walter NAR, Darakjian P, Oberbeck DL, Daunais JB, Zheng CL, Searles RP, McWeeney SK, Grant KA, Mayfield RD. Cross-species molecular dissection across alcohol behavioral domains. Alcohol 2018; 72:19-31. [PMID: 30213503 PMCID: PMC6309876 DOI: 10.1016/j.alcohol.2017.11.036] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2017] [Revised: 11/17/2017] [Accepted: 11/28/2017] [Indexed: 12/14/2022]
Abstract
This review summarizes the proceedings of a symposium presented at the "Alcoholism and Stress: A Framework for Future Treatment Strategies" conference held in Volterra, Italy on May 9-12, 2017. Psychiatric diseases, including alcohol-use disorders (AUDs), are influenced through complex interactions of genes, neurobiological pathways, and environmental influences. A better understanding of the common neurobiological mechanisms underlying an AUD necessitates an integrative approach, involving a systematic assessment of diverse species and phenotype measures. As part of the World Congress on Stress and Alcoholism, this symposium provided a detailed account of current strategies to identify mechanisms underlying the development and progression of AUDs. Dr. Sean Farris discussed the integration and organization of transcriptome and postmortem human brain data to identify brain regional- and cell type-specific differences related to excessive alcohol consumption that are conserved across species. Dr. Brien Riley presented the results of a genome-wide association study of DSM-IV alcohol dependence; although replication of genetic associations with alcohol phenotypes in humans remains challenging, model organism studies show that COL6A3, KLF12, and RYR3 affect behavioral responses to ethanol, and provide substantial evidence for their role in human alcohol-related traits. Dr. Rob Williams expanded upon the systematic characterization of extensive genetic-genomic resources for quantifying and clarifying phenotypes across species that are relevant to precision medicine in human disease. The symposium concluded with Dr. Robert Hitzemann's description of transcriptome studies in a mouse model selectively bred for high alcohol ("binge-like") consumption and a non-human primate model of long-term alcohol consumption. Together, the different components of this session provided an overview of systems-based approaches that are pioneering the experimental prioritization and validation of novel genes and gene networks linked with a range of behavioral phenotypes associated with stress and AUDs.
Collapse
Affiliation(s)
- Sean P Farris
- University of Texas at Austin, Austin, TX, United States
| | - Brien P Riley
- Virginia Commonwealth University, Richmond, VA, United States
| | - Robert W Williams
- University of Tennessee Health Science Center, Memphis, TN, United States
| | - Megan K Mulligan
- University of Tennessee Health Science Center, Memphis, TN, United States
| | - Michael F Miles
- University of Tennessee Health Science Center, Memphis, TN, United States
| | - Marcelo F Lopez
- University of Tennessee Health Science Center, Memphis, TN, United States
| | - Robert Hitzemann
- Oregon Health and Science University, Portland, OR, United States
| | - Ovidiu D Iancu
- Oregon Health and Science University, Portland, OR, United States
| | | | | | | | | | - James B Daunais
- Wake Forest School of Medicine, Winston-Salem, NC, United States
| | | | - Robert P Searles
- Oregon Health and Science University, Portland, OR, United States
| | | | - Kathleen A Grant
- Oregon Health and Science University, Portland, OR, United States
| | | |
Collapse
|
5
|
Chakravorty S, Chaudhary NS, Morales K, Grandner MA, Oslin DW. Is family history of alcohol dependence a risk factor for disturbed sleep in alcohol dependent subjects? Drug Alcohol Depend 2018; 188:311-317. [PMID: 29843109 PMCID: PMC7486904 DOI: 10.1016/j.drugalcdep.2018.04.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 04/08/2018] [Accepted: 04/10/2018] [Indexed: 11/24/2022]
Abstract
BACKGROUND Disturbed sleep and a family history of alcohol dependence (AD) are risk factors for developing AD, yet the underlying relationship between them is unclear among individuals with AD. Understanding these inherited associations will help us not only identify risk for development of these comorbid disorders, but also individualize treatment at this interface. We evaluated whether a first-degree family history of AD (FH+) was a risk factor for sleep continuity disturbance in patients with AD. We also evaluated whether alcohol use or mood disturbance moderated the relationship between FH and sleep. METHODS We analyzed cross-sectional baseline data from an alcohol clinical trial in a sample of individuals with AD (N = 280). Their family history of AD among nuclear family members, sleep complaints, alcohol use (over the last 90 days), and mood disturbance were assessed using the Family History Interview for Substance and Mood Disorders, Medical Outcomes Study Sleep Scale, Time Line Follow-Back Interview, and Profile of Mood States-Short Form, respectively. RESULTS A FH + status (65% of subjects) was significantly associated with lower model estimated mean sleep adequacy (β = - 7.05, p = 0.02) and sleep duration (β = - 0.38, p = 0.04) scale scores. FH was not associated with sleep disturbance scale. No significant moderating effect involving alcohol use or mood disturbance was seen. CONCLUSION Family history of AD is a unique risk factor for sleep complaints in AD. Non-restorative sleep and sleep duration may be noteworthy phenotypes to help probe for underlying genotypic polymorphisms in these comorbid disorders.
Collapse
Affiliation(s)
- Subhajit Chakravorty
- Cpl. Michael J. Crescenz VA Medical Center, 3900 Woodland Ave., Philadelphia, PA 19104, USA; Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd., Philadelphia, PA 19104, USA.
| | | | | | | | - David W. Oslin
- Cpl. Michael J. Crescenz VA Medical Center, Philadelphia, PA 19104;,Perelman School of Medicine, Philadelphia, PA 19104
| |
Collapse
|
6
|
Dick DM, Barr P, Guy M, Nasim A, Scott D. Review: Genetic research on alcohol use outcomes in African American populations: A review of the literature, associated challenges, and implications. Am J Addict 2017; 26:486-493. [PMID: 28240821 PMCID: PMC5884102 DOI: 10.1111/ajad.12495] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2016] [Revised: 11/18/2016] [Accepted: 12/18/2016] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND AND OBJECTIVES There have been remarkable advances in understanding genetic influences on complex traits; however, individuals of African descent have been underrepresented in genetic research. METHODS We review the limitations of existing genetic research on alcohol phenotypes in African Americans (AA) including both twin and gene identification studies, possible reasons for underrepresentation of AAs in genetic research, the implications of the lack of racially diverse samples, and special considerations regarding conducting genetic research in AA populations. RESULTS There is a marked absence of large-scale AA twin studies so little is known about the genetic epidemiology of alcohol use and problems among AAs. Individuals of African descent have also been underrepresented in gene identification efforts; however, there have been recent efforts to enhance representation. It remains unknown the extent to which genetic variants associated with alcohol use outcomes in individuals of European and African descent will be shared. Efforts to increase representation must be accompanied by careful attention to the ethical, legal, and social implications of genetic research. This is particularly true for AAs due to the history of abuse by the biomedical community and the persistent racial discrimination targeting this population. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE Lack of representation in genetic studies limits our understanding of the etiological factors that contribute to substance use and psychiatric outcomes in populations of African descent and has the potential to further perpetuate health disparities. Involving individuals of diverse ancestry in discussions about genetic research will be critical to ensure that all populations benefit equally from genetic advances. (Am J Addict 2017;26:486-493).
Collapse
Affiliation(s)
- Danielle M Dick
- Department of Psychology, Virginia Commonwealth University, Richmond, Virginia
- Department of African American Studies, Virginia Commonwealth University, Richmond, Virginia
- Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, Virginia
| | - Peter Barr
- Department of Psychology, Virginia Commonwealth University, Richmond, Virginia
- Department of African American Studies, Virginia Commonwealth University, Richmond, Virginia
| | - Mignonne Guy
- Department of African American Studies, Virginia Commonwealth University, Richmond, Virginia
| | - Aashir Nasim
- Department of African American Studies, Virginia Commonwealth University, Richmond, Virginia
| | - Denise Scott
- Department of Pediatrics and Human Genetics and Alcohol Research Center, Howard University College of Medicine, Washington, District of Columbia
| |
Collapse
|
7
|
Adkins AE, Hack LM, Bigdeli TB, Williamson VS, McMichael GO, Mamdani M, Edwards A, Aliev F, Chan RF, Bhandari P, Raabe RC, Alaimo JT, Blackwell GG, Moscati AA, Poland RS, Rood B, Patterson DG, Walsh D, Whitfield JB, Zhu G, Montgomery GW, Henders AK, Martin NG, Heath AC, Madden PA, Frank J, Ridinger M, Wodarz N, Soyka M, Zill P, Ising M, Nöthen MM, Kiefer F, Rietschel M, Gelernter J, Sherva R, Koesterer R, Almasy L, Zhao H, Kranzler HR, Farrer LA, Maher BS, Prescott CA, Dick DM, Bacanu SA, Mathies LD, Davies AG, Vladimirov VI, Grotewiel M, Bowers MS, Bettinger JC, Webb BT, Miles MF, Kendler KS, Riley BP. Genomewide Association Study of Alcohol Dependence Identifies Risk Loci Altering Ethanol-Response Behaviors in Model Organisms. Alcohol Clin Exp Res 2017; 41:911-928. [PMID: 28226201 PMCID: PMC5404949 DOI: 10.1111/acer.13362] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2016] [Accepted: 02/16/2017] [Indexed: 01/23/2023]
Abstract
BACKGROUND Alcohol dependence (AD) shows evidence for genetic liability, but genes influencing risk remain largely unidentified. METHODS We conducted a genomewide association study in 706 related AD cases and 1,748 unscreened population controls from Ireland. We sought replication in 15,496 samples of European descent. We used model organisms (MOs) to assess the role of orthologous genes in ethanol (EtOH)-response behaviors. We tested 1 primate-specific gene for expression differences in case/control postmortem brain tissue. RESULTS We detected significant association in COL6A3 and suggestive association in 2 previously implicated loci, KLF12 and RYR3. None of these signals are significant in replication. A suggestive signal in the long noncoding RNA LOC339975 is significant in case:control meta-analysis, but not in a population sample. Knockdown of a COL6A3 ortholog in Caenorhabditis elegans reduced EtOH sensitivity. Col6a3 expression correlated with handling-induced convulsions in mice. Loss of function of the KLF12 ortholog in C. elegans impaired development of acute functional tolerance (AFT). Klf12 expression correlated with locomotor activation following EtOH injection in mice. Loss of function of the RYR3 ortholog reduced EtOH sensitivity in C. elegans and rapid tolerance in Drosophila. The ryanodine receptor antagonist dantrolene reduced motivation to self-administer EtOH in rats. Expression of LOC339975 does not differ between cases and controls but is reduced in carriers of the associated rs11726136 allele in nucleus accumbens (NAc). CONCLUSIONS We detect association between AD and COL6A3, KLF12, RYR3, and LOC339975. Despite nonreplication of COL6A3, KLF12, and RYR3 signals, orthologs of these genes influence behavioral response to EtOH in MOs, suggesting potential involvement in human EtOH response and AD liability. The associated LOC339975 allele may influence gene expression in human NAc. Although the functions of long noncoding RNAs are poorly understood, there is mounting evidence implicating these genes in multiple brain functions and disorders.
Collapse
Affiliation(s)
- Amy E. Adkins
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Laura M. Hack
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Tim B. Bigdeli
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Vernell S. Williamson
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - G. Omari McMichael
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Mohammed Mamdani
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Alexis Edwards
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Fazil Aliev
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Robin F. Chan
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Poonam Bhandari
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Richard C. Raabe
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Joseph T. Alaimo
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - GinaMari G. Blackwell
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Arden A. Moscati
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Ryan S. Poland
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Benjamin Rood
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Diana G. Patterson
- Shaftesbury Square Hospital, 116-120 Great Victoria Street, Belfast,
BT2 7BG, United Kingdom
| | - Dermot Walsh
- Health Research Board, 67-72 Lower Mount Street, Dublin 2,
Ireland
| | | | - John B. Whitfield
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute,
Royal Brisbane and Women’s Hospital, 300 Herston Road, Brisbane, QLD 4006,
Australia
| | - Gu Zhu
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute,
Royal Brisbane and Women’s Hospital, 300 Herston Road, Brisbane, QLD 4006,
Australia
| | - Grant W. Montgomery
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute,
Royal Brisbane and Women’s Hospital, 300 Herston Road, Brisbane, QLD 4006,
Australia
| | - Anjali K. Henders
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute,
Royal Brisbane and Women’s Hospital, 300 Herston Road, Brisbane, QLD 4006,
Australia
| | - Nicholas G. Martin
- Genetic Epidemiology, QIMR Berghofer Medical Research Institute,
Royal Brisbane and Women’s Hospital, 300 Herston Road, Brisbane, QLD 4006,
Australia
| | - Andrew C. Heath
- Department of Psychiatry, Washington University School of Medicine,
4560 Clayton Ave., Suite 1000, St. Louis, MO, 63110, USA
| | - Pamela A.F. Madden
- Department of Psychiatry, Washington University School of Medicine,
4560 Clayton Ave., Suite 1000, St. Louis, MO, 63110, USA
| | - Josef Frank
- Department of Genetic Epidemiology in Psychiatry, Central Institute
of Mental Health, Medical Faculty Mannheim/Heidelberg University, J 5, 68159
Mannheim, Germany
| | - Monika Ridinger
- Department of Psychiatry, University Hospital Regensburg,
University of Regensburg, 93042 Regensburg, Germany
| | - Norbert Wodarz
- Department of Psychiatry, University Hospital Regensburg,
University of Regensburg, 93042 Regensburg, Germany
| | - Michael Soyka
- Privatklinik Meiringen, Willigen, 3860 Meiringen, Switzerland
- Department of Psychiatry and Psychotherapy, University of Munich,
Nussbaumstrasse 7, 80336 Munich, Germany
| | - Peter Zill
- Department of Psychiatry and Psychotherapy, University of Munich,
Nussbaumstrasse 7, 80336 Munich, Germany
| | - Marcus Ising
- Department of Molecular Psychology, Max-Planck-Institute of
Psychiatry, Kraepelinstrasse 2–10, 80804 Munich, Germany
| | - Markus M Nöthen
- Department of Genomics, Life & Brain Center, University of
Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany
- Department of Institute of Human Genetics, University of Bonn,
Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany
- German Center for Neurodegenerative Diseases (DZNE), University of
Bonn, Sigmund-Freud-Strasse 25, D-53127 Bonn, Germany
| | - Falk Kiefer
- Department of Addictive Behavior and Addiction Medicine, Central
Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, J 5,
68159 Mannheim, Germany
| | - Marcella Rietschel
- Department of Genetic Epidemiology in Psychiatry, Central Institute
of Mental Health, Medical Faculty Mannheim/Heidelberg University, J 5, 68159
Mannheim, Germany
| | | | - Joel Gelernter
- Department of Psychiatry, Yale University School of Medicine, 333
Cedar Street, New Haven, CT, 06510, USA
- Department of Neurobiology, Yale University School of Medicine, 333
Cedar Street, New Haven, CT, 06510, USA
- Department of Genetics, Yale University School of Medicine, 333
Cedar Street, New Haven, CT, 06510, USA
- Department of Psychiatry, VA CT Healthcare Center, 950 Campbell
Avenue, West Haven, CT, 06516, USA
| | - Richard Sherva
- Department of Medicine (Biomedical Genetics), Boston University
School of Medicine, 72 East Concord Street, Boston, MA, 02118, USA
| | - Ryan Koesterer
- Department of Medicine (Biomedical Genetics), Boston University
School of Medicine, 72 East Concord Street, Boston, MA, 02118, USA
| | - Laura Almasy
- Texas Biomedical Research Institute, Department of Genetics, P.O.
Box 760549, San Antonio, TX, 78245-0549, USA
| | - Hongyu Zhao
- Department of Genetics, Yale University School of Medicine, 333
Cedar Street, New Haven, CT, 06510, USA
- Department of Biostatistics, Yale University School of Medicine,
333 Cedar Street, New Haven, CT, 06510, USA
| | - Henry R. Kranzler
- Department of Psychiatry, University of Pennsylvania Perelman
School of Medicine, Treatment Research Center, 3900 Chestnut Street, Philadelphia,
PA 19104, USA
- VISN 4 MIRECC, Philadelphia VA Medical Center, 3900 Woodland
Avenue, Philadelphia, PA, 19104, USA
| | - Lindsay A. Farrer
- Department of Psychiatry, VA CT Healthcare Center, 950 Campbell
Avenue, West Haven, CT, 06516, USA
- Department of Neurology, Boston University School of Medicine, 72
East Concord Street, Boston, MA, 02118, USA
- Department of Ophthalmology, Boston University School of Medicine,
72 East Concord Street, Boston, MA, 02118, USA
- Department of Genetics and Genomics, Boston University School of
Medicine, 72 East Concord Street, Boston, MA, 02118, USA
- Department of Epidemiology and Biostatistics, Boston University
School of Public Health, 715 Albany Street, Boston, MA, 02118, USA
| | - Brion S. Maher
- Department of Mental Health, Johns Hopkins Bloomberg School of
Public Health, 624 N. Broadway, 8th Floor, Baltimore, MD, 21205, USA
| | - Carol A. Prescott
- Department of Psychology, University of Southern California, SGM
501, 3620 South McClintock Ave., Los Angeles, CA, 90089-1061, USA
| | - Danielle M. Dick
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Silviu A. Bacanu
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Laura D. Mathies
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Andrew G. Davies
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Vladimir I. Vladimirov
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
- Lieber Institute for Brain Development, Johns Hopkins University,
855 North Wolfe Street Suite 300, Baltimore, MD, 21205, USA
- Center for Biomarker Research and Personalized Medicine, School of
Pharmacy, PO Box 980533, Virginia Commonwealth University, Richmond, VA 23298-0533,
USA
| | - Mike Grotewiel
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - M. Scott Bowers
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Jill C. Bettinger
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Bradley T. Webb
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
| | - Michael F. Miles
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Pharmacology & Toxicology, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Kenneth S. Kendler
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| | - Brien P. Riley
- Virginia Commonwealth University Alcohol Research Center, PO Box
980424, Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
- Department of Psychiatry, PO Box 980424, Virginia Commonwealth
University, Richmond, VA, 23298-0424, USA
- Department of Human & Molecular Genetics, PO Box 980424,
Virginia Commonwealth University, Richmond, VA, 23298-0424, USA
| |
Collapse
|
8
|
Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. J Hepatol 2017; 66:195-211. [PMID: 27575312 DOI: 10.1016/j.jhep.2016.08.011] [Citation(s) in RCA: 100] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Revised: 08/15/2016] [Accepted: 08/16/2016] [Indexed: 12/19/2022]
Abstract
The susceptibility to developing alcohol dependence and significant alcohol-related liver injury is determined by a number of constitutional, environmental and genetic factors, although the nature and level of interplay between them remains unclear. The familiality and heritability of alcohol dependence is well-documented but, to date, no strong candidate genes conferring increased risk have emerged, although variants in alcohol dehydrogenase and acetaldehyde dehydrogenase have been shown to confer protection, predominantly in individuals of East Asian ancestry. Population contamination with confounders such as drug co-dependence and psychiatric and physical co-morbidity may explain the essentially negative genome-wide association studies in this disorder. The familiality and hereditability of alcohol-related cirrhosis is not as well-documented but three strong candidate genes PNPLA3, TM6SF2 and MBOAT7, have been identified. The mechanisms by which variants in these genes confer risk and the nature of the functional interplay between them remains to be determined but, when elucidated, will undoubtedly increase our understanding of the pathophysiology of this disease. The way in which this genetic information could potentially inform patient management has yet to be determined and tested.
Collapse
Affiliation(s)
- Felix Stickel
- Department of Gastroenterology and Hepatology, University Hospital of Zurich, Switzerland.
| | - Christophe Moreno
- Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium
| | - Jochen Hampe
- Medical Department 1, University Hospital Dresden, TU Dresden, Germany
| | - Marsha Y Morgan
- UCL Institute for Liver & Digestive Health, Division of Medicine, Royal Free Campus, University College London, UK
| |
Collapse
|
9
|
Yazbek JC, Haddad R, Bou Khalil R, Hlais S, Rizk GA, Rohayem J, Richa S. Prevalence and correlates of alcohol abuse and dependence in Lebanon: results from the Lebanese Epidemiologic Survey on Alcohol (LESA). J Addict Dis 2015; 33:221-33. [PMID: 25115340 DOI: 10.1080/10550887.2014.950026] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The current article aimed to determine the 12-month prevalence and correlates of DSM-IV alcohol abuse and dependence in a nationally representative sample of Lebanese adults. One thousand participants collaborated in face-to-face interviews in 2011. Prevalence of 12-month alcohol dependence was 5%, with a higher risk for those who were men, unmarried, the youngest adults (aged between 18 and 34 years old), students, participants with a liberal occupation, participants with a low income, participants with a positive family history of alcohol misuse, and smokers. Prevalence of 12-month alcohol abuse was 6.2%, with a higher risk for those who were men, students, employees, and Druze and Christians compared to Muslims. Current alcohol abuse and dependence were found to be very highly prevalent in Lebanon.
Collapse
Affiliation(s)
- Jean-Claude Yazbek
- a Department of Psychiatry , Lebanese American University , Beirut , Lebanon
| | | | | | | | | | | | | |
Collapse
|
10
|
Wilhelm CJ, Hashimoto JG, Roberts ML, Bloom SH, Beard DK, Wiren KM. Females uniquely vulnerable to alcohol-induced neurotoxicity show altered glucocorticoid signaling. Brain Res 2015; 1601:102-16. [PMID: 25601008 DOI: 10.1016/j.brainres.2015.01.002] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 10/28/2014] [Accepted: 01/01/2015] [Indexed: 12/29/2022]
Abstract
Women are more sensitive to the harmful effects of alcohol (EtOH) abuse than men, yet the underlying mechanisms remain poorly understood. Previous gene expression analysis of the medial prefrontal cortex (mPFC) following a chronic intoxication paradigm using continuous 72 h vapor inhalation found that females, but not males, exhibit an inflammatory response at peak withdrawal that is associated with cell damage. Given that glucocorticoids can function as anti-inflammatories, are known to increase with EtOH exposure, and influence neurotoxicity, we hypothesized that males and females may exhibit an altered corticosterone (CORT) response following chronic intoxication. Analysis of serum CORT levels revealed the expected increase during withdrawal with no difference between males and females, while control males but not females exhibited higher CORT concentrations than naive animals. Glucocorticoid signaling characterized using focused qPCR arrays identified a sexually dimorphic response in the mPFC during withdrawal, particularly among astrocyte-enriched genes. These genes include aquaporin-1 (Aqp1), sphingosine kinase 1 (Sphk1) and connective tissue growth factor (Ctgf); genes associated with inflammatory signaling, and tissue damage and repair. Bioinformatic analysis also revealed activation of inflammatory signaling and cell death pathways in females. Confirmation studies showed that female mice exhibited significant neuronal degeneration within the anterior cingulate cortex (ACC). By contrast, EtOH exposure lead to a significant reduction in cell death in males. Thus, distinct glucocorticoid signaling pathways are associated with sexually dimorphic neurotoxicity, suggesting one mechanism by which EtOH-exposed females are particularly vulnerable to the damaging effects of alcohol in the CNS.
Collapse
Affiliation(s)
- Clare J Wilhelm
- VA Portland Health Care System, Portland, OR 97239, USA; Department of Psychiatry, Oregon Health & Science University, Portland, OR 97239, USA.
| | - Joel G Hashimoto
- VA Portland Health Care System, Portland, OR 97239, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA
| | | | | | | | - Kristine M Wiren
- VA Portland Health Care System, Portland, OR 97239, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA
| |
Collapse
|
11
|
Wilhelm CJ, Hashimoto JG, Roberts ML, Sonmez MK, Wiren KM. Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage. Neuroscience 2014; 279:168-86. [PMID: 25194791 PMCID: PMC4224688 DOI: 10.1016/j.neuroscience.2014.08.041] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2014] [Revised: 08/25/2014] [Accepted: 08/26/2014] [Indexed: 02/07/2023]
Abstract
Ethanol abuse can lead to addiction, brain damage and premature death. The cycle of alcohol addiction has been described as a composite consisting of three stages: intoxication, withdrawal and craving/abstinence. There is evidence for contributions of both genotype and sex to alcoholism, but an understanding of the biological underpinnings is limited. Utilizing both sexes of genetic animal models with highly divergent alcohol withdrawal severity, Withdrawal Seizure-Resistant (WSR) and Withdrawal Seizure-Prone (WSP) mice, the distinct contributions of genotype/phenotype and of sex during addiction stages on neuroadaptation were characterized. Transcriptional profiling was performed to identify expression changes as a consequence of chronic intoxication in the medial prefrontal cortex. Significant expression differences were identified on a single platform and tracked over a behaviorally relevant time course that covered each stage of alcohol addiction; i.e., after chronic intoxication, during peak withdrawal, and after a defined period of abstinence. Females were more sensitive to ethanol with higher fold expression differences. Bioinformatics showed a strong effect of sex on the data structure of expression profiles during chronic intoxication and at peak withdrawal irrespective of genetic background. However, during abstinence, differences were observed instead between the lines/phenotypes irrespective of sex. Confirmation of identified pathways showed distinct inflammatory signaling following intoxication at peak withdrawal, with a pro-inflammatory phenotype in females but overall suppression of immune signaling in males. Combined, these results suggest that each stage of the addiction cycle is influenced differentially by sex vs. genetic background and support the development of stage- and sex-specific therapies for alcohol withdrawal and the maintenance of sobriety.
Collapse
Affiliation(s)
- C J Wilhelm
- Department of Veterans Affairs Medical Center, Portland, OR 97239, USA; Department of Psychiatry, Oregon Health & Science University, Portland, OR 97239, USA.
| | - J G Hashimoto
- Department of Veterans Affairs Medical Center, Portland, OR 97239, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA
| | - M L Roberts
- Department of Veterans Affairs Medical Center, Portland, OR 97239, USA
| | - M K Sonmez
- Center For Spoken Language Understanding, Oregon Health & Science University, Portland, OR 97239, USA
| | - K M Wiren
- Department of Veterans Affairs Medical Center, Portland, OR 97239, USA; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR 97239, USA
| |
Collapse
|
12
|
Brody GH, Beach SRH, Hill KG, Howe GW, Prado G, Fullerton SM. Using genetically informed, randomized prevention trials to test etiological hypotheses about child and adolescent drug use and psychopathology. Am J Public Health 2013; 103 Suppl 1:S19-24. [PMID: 23927515 DOI: 10.2105/ajph.2012.301080] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
In this essay, we describe a new era of public health research in which prevention science principles are combined with genomic science to produce gene × intervention (G × I) research. We note the roles of behavioral and molecular genetics in risk and protective mechanisms for drug use and psychopathology among children and adolescents, and the results of first-generation genetically informed prevention trials are reviewed. We also consider the need for second-generation research that focuses on G × I effects on mediators or intermediate processes. This research can be used to further understanding of etiological processes, to identify individual differences in children's and adolescents' responses to risk, and to increase the precision of prevention programs. We note the caveats about using genetic data to select intervention participants.
Collapse
Affiliation(s)
- Gene H Brody
- Gene H. Brody and Steven R. H. Beach are with the Center for Family Research, University of Georgia, Athens. Karl G. Hill is with the School of Social Work, University of Washington, Seattle. George W. Howe is with the Department of Psychology, George Washington University, Washington, DC. Guillermo Prado is with the Department of Epidemiology and Public Health, University of Miami, Miami, FL. Stephanie M. Fullerton is with the Department of Bioethics and Humanities, University of Washington
| | | | | | | | | | | |
Collapse
|
13
|
Magnusson Å, Lundholm C, Göransson M, Copeland W, Heilig M, Pedersen NL. Familial influence and childhood trauma in female alcoholism. Psychol Med 2012; 42:381-389. [PMID: 21798111 PMCID: PMC3648622 DOI: 10.1017/s0033291711001310] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
BACKGROUND To assess the role of genetic and environmental factors in female alcoholism using a large population-based twin sample, taking into account possible differences between early and late onset disease subtype. METHOD Twins aged 20-47 years from the Swedish Twin Registry (n=24 119) answered questions to establish lifetime alcohol use disorders. Subjects with alcoholism were classified for subtype. Structural equation modeling was used to quantify the proportion of phenotypic variance due to genetic and environmental factors and test whether heritability in women differed from that in men. The association between childhood trauma and alcoholism was then examined in females, controlling for background familial factors. RESULTS Lifetime prevalence of alcohol dependence was 4.9% in women and 8.6% in men. Overall, heritability for alcohol dependence was 55%, and did not differ significantly between men and women, although women had a significantly greater heritability for late onset (type I). Childhood physical trauma and sexual abuse had a stronger association with early onset compared to late onset alcoholism [odds ratio (OR) 2.54, 95% confidence interval (CI) 1.53-3.88 and OR 2.29, 95% CI 1.38-3.79 respectively]. Co-twin analysis indicated that familial factors largely accounted for the influence of physical trauma whereas the association with childhood sexual abuse reflected both familial and specific effects. CONCLUSIONS Heritability of alcoholism in women is similar to that in men. Early onset alcoholism is strongly association with childhood trauma, which seems to be both a marker of familial background factors and a specific individual risk factor per se.
Collapse
Affiliation(s)
- Å. Magnusson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - C. Lundholm
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - M. Göransson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - W. Copeland
- Center for Developmental Epidemiology, Duke University, Durham, NC, USA
| | - M. Heilig
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
| | - N. L. Pedersen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| |
Collapse
|
14
|
Lydall GJ, Bass NJ, McQuillin A, Lawrence J, Anjorin A, Kandaswamy R, Pereira A, Guerrini I, Curtis D, Vine AE, Sklar P, Purcell SM, Gurling HMD. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr Genet 2011; 21:294-306. [PMID: 21876473 PMCID: PMC3372889 DOI: 10.1097/ypg.0b013e32834915c2] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVES Alcoholism and affective disorders are both strongly comorbid and heritable. We have investigated the genetic comorbidity between bipolar affective disorder and alcoholism. METHODS A genome-wide allelic association study of 506 patients from the University College London bipolar disorder case-control sample and 510 ancestrally matched supernormal controls. One hundred forty-three of the bipolar patients fulfilled the Research Diagnostic Criteria diagnosis of alcoholism. A total of 372 193 single nucleotide polymorphisms (SNPs) were genotyped. Genes previously shown to be associated with alcoholism and addiction phenotypes were then tested for association in the bipolar alcoholic sample using gene-wise permutation tests of all SNPs genotyped within a 50-kb region flanking each gene. RESULTS Several central nervous system genes showed significant (P<0.05) gene-wise evidence of association with bipolar alcoholism. The genes implicated, which replicated genes previously shown to be associated with alcoholism were: cadherin 11, collagen type 11 α2, neuromedin U receptor 2, exportin7, and semaphorin-associated protein 5A. The SNPs most strongly implicated in bipolar alcoholism, but, which did not meet conventional genome-wide significance criteria were the insulin-like growth factor-binding protein 7, carboxypeptidase O, cerebellin 2, and the cadherin 12 genes. CONCLUSION We have confirmed the role of some genes previously shown to be associated with alcoholism in the comorbid bipolar alcoholism subgroup. In this subgroup, bipolar disorder may lower the threshold for the phenotypic expression of these alcoholism susceptibility genes. We also show that some genes may independently increase susceptibility to affective disorder and alcoholism.
Collapse
Affiliation(s)
- Gregory John Lydall
- Department of Mental Health Sciences, University College London, Molecular Psychiatry Laboratory, Harvard Medical School, Boston, Massachusetts, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Young-Wolff KC, Enoch MA, Prescott CA. The influence of gene-environment interactions on alcohol consumption and alcohol use disorders: a comprehensive review. Clin Psychol Rev 2011; 31:800-16. [PMID: 21530476 PMCID: PMC3192029 DOI: 10.1016/j.cpr.2011.03.005] [Citation(s) in RCA: 114] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2010] [Revised: 03/09/2011] [Accepted: 03/09/2011] [Indexed: 01/08/2023]
Abstract
Since 2005, a rapidly expanding literature has evaluated whether environmental factors such as socio-cultural context and adversity interact with genetic influences on drinking behaviors. This article critically reviews empirical research on alcohol-related genotype-environment interactions (GxE) and provides a contextual framework for understanding how genetic factors combine with (or are shaped by) environmental factors to influence the development of drinking behaviors and alcohol use disorders. Collectively, evidence from twin, adoption, and molecular genetic studies indicates that the degree of importance of genetic influences on risk for drinking outcomes can vary in different populations and under different environmental circumstances. However, methodological limitations and lack of consistent replications in this literature make it difficult to draw firm conclusions regarding the nature and effect size of alcohol-related GxE. On the basis of this review, we describe several methodological challenges as they relate to current research on GxE in drinking behaviors and provide recommendations to aid future research.
Collapse
|
16
|
Forquer MR, Hashimoto JG, Roberts ML, Wiren KM. Elevated testosterone in females reveals a robust sex difference in altered androgen levels during chronic alcohol withdrawal. Alcohol 2011; 45:161-71. [PMID: 20843636 DOI: 10.1016/j.alcohol.2010.08.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2010] [Revised: 07/19/2010] [Accepted: 08/14/2010] [Indexed: 01/11/2023]
Abstract
The endocrine disruption associated with alcohol (ethanol) abuse in both males and females is widely recognized. Ethanol intoxication and withdrawal in males results in significant reductions in androgen levels. Less is known about female alcoholics, and because the changes in testosterone concentrations remain controversial, we systematically characterized changes in sex steroids after chronic ethanol exposure and withdrawal in both sexes. Testosterone and 17β-estradiol concentrations were determined during chronic high intoxication, over a withdrawal time course, and following a period of abstinence using a genetic model of withdrawal vulnerability, the Withdrawal Seizure-Resistant (WSR) and -Prone (WSP) selected lines. In males, testosterone concentrations were significantly lower in intoxicated WSP mice after chronic ethanol exposure, and were dramatically and transiently reduced during the withdrawal period in both WSR and WSP lines. In contrast, testosterone levels were increased in intoxicated WSP females and in both WSR and WSP mice during withdrawal. Chronic ethanol exposure disrupted normal estrous cycling in WSP mice, associated with hyperandrogenemia while intoxicated. In abstinence, elevated testosterone was observed in both sexes but only in WSR mice. Estrogen levels were modestly reduced during withdrawal in both WSR and WSP lines, predominantly in males. These findings identify a mechanism based on altered androgen signaling that likely contributes to sex-specific responses during withdrawal. However, only WSR mice showed similar elevations in androgen long after withdrawal in both sexes, suggesting that genotype is an important determinant of steroid responses after abstinence. Increased androgen signaling in females as a consequence of chronic ethanol exposure may play an important and relatively uncharacterized role in sexually dimorphic responses to alcohol abuse.
Collapse
|
17
|
Hashimoto JG, Forquer MR, Tanchuck MA, Finn DA, Wiren KM. Importance of genetic background for risk of relapse shown in altered prefrontal cortex gene expression during abstinence following chronic alcohol intoxication. Neuroscience 2010; 173:57-75. [PMID: 21081154 DOI: 10.1016/j.neuroscience.2010.11.006] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2010] [Revised: 10/21/2010] [Accepted: 11/05/2010] [Indexed: 11/19/2022]
Abstract
Alcoholism is a relapsing disorder associated with excessive consumption after periods of abstinence. Neuroadaptations in brain structure, plasticity and gene expression occur with chronic intoxication but are poorly characterized. Here we report identification of pathways altered during abstinence in prefrontal cortex, a brain region associated with cognitive dysfunction and damage in alcoholics. To determine the influence of genetic differences, an animal model was employed with widely divergent responses to alcohol withdrawal, the Withdrawal Seizure-Resistant (WSR) and Withdrawal Seizure-Prone (WSP) lines. Mice were chronically exposed to highly intoxicating concentrations of ethanol and withdrawn, then left abstinent for 21 days. Transcriptional profiling by microarray analyses identified a total of 562 genes as significantly altered during abstinence. Hierarchical cluster analysis revealed that the transcriptional response correlated with genotype/withdrawal phenotype rather than sex. Gene Ontology category overrepresentation analysis identified thyroid hormone metabolism, glutathione metabolism, axon guidance and DNA damage response as targeted classes of genes in low response WSR mice, with acetylation and histone deacetylase complex as highly dimorphic between WSR and WSP mice. Confirmation studies in WSR mice revealed both increased neurotoxicity by histopathologic examination and elevated triidothyronine (T3) levels. Most importantly, relapse drinking was reduced by inhibition of thyroid hormone synthesis in dependent WSR mice compared to controls. These findings provide in vivo physiological and behavioral validation of the pathways identified. Combined, these results indicate a fundamentally distinct neuroadaptive response during abstinence in mice genetically selected for divergent withdrawal severity. Identification of pathways altered in abstinence may aid development of novel therapeutics for targeted treatment of relapse in abstinent alcoholics.
Collapse
Affiliation(s)
- J G Hashimoto
- Research Service, Portland Veterans Affairs Medical Center, Portland, OR 97239, USA
| | | | | | | | | |
Collapse
|
18
|
Cerdá M, Sagdeo A, Johnson J, Galea S. Genetic and environmental influences on psychiatric comorbidity: a systematic review. J Affect Disord 2010; 126:14-38. [PMID: 20004978 PMCID: PMC2888715 DOI: 10.1016/j.jad.2009.11.006] [Citation(s) in RCA: 84] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2009] [Revised: 11/10/2009] [Accepted: 11/12/2009] [Indexed: 11/25/2022]
Abstract
BACKGROUND The purpose of this review is to systematically appraise the peer-reviewed literature about the genetic and environmental determinants of psychiatric comorbidity, focusing on four of the most prevalent types of psychopathology: anxiety disorders, depression, conduct disorder and substance abuse. METHODS We summarize existing empirical research on the relative contribution that genetic, nonshared and shared environmental factors make to the covariance between disorders, and evidence about specific genes and environmental characteristics that are associated with comorbidity. RESULTS Ninety-four articles met the inclusion criteria and were assessed. Genetic factors play a particularly strong role in comorbidity between major depression and generalized anxiety disorder or posttraumatic stress disorder, while the non-shared environments make an important contribution to comorbidity in affective disorders. Genetic and non-shared environmental factors also make a moderate-to-strong contribution to the relationship between CD and SA. A range of candidate genes, such as 5HTTLPR, MAOA, and DRD1-DRD4, as well as others implicated in the central nervous system, has been implicated in psychiatric comorbidity. Pivotal social factors include childhood adversity/life events, family and peer social connections, and socioeconomic and academic difficulties. LIMITATIONS Methodological concerns include the use of clinical case-control samples, the focus on a restricted set of individual-level environmental risk factors, and restricted follow-up times. CONCLUSIONS Given the significant mental health burden associated with comorbid disorders, population-based research on modifiable risk factors for psychiatric comorbidity is vital for the design of effective preventive and clinical interventions.
Collapse
Affiliation(s)
- M Cerdá
- Center for Urban Epidemiologic Studies, New York Academy of Medicine, New York, NY, 10029, USA.
| | | | | | | |
Collapse
|
19
|
Ehlers CL, Gizer IR, Vieten C, Gilder A, Gilder DA, Stouffer GM, Lau P, Wilhelmsen KC. Age at regular drinking, clinical course, and heritability of alcohol dependence in the San Francisco family study: a gender analysis. Am J Addict 2010; 19:101-10. [PMID: 20163381 DOI: 10.1111/j.1521-0391.2009.00021.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
We examined gender differences in age of onset, clinical course, and heritability of alcohol dependence in 2,524 adults participating in the University of California San Francisco (UCSF) family study of alcoholism. Men were significantly more likely than women to have initiated regular drinking during adolescence. Onset of regular drinking was not found to be heritable but was found to be significantly associated with a shorter time to onset of alcohol dependence. A high degree of similarity in the sequence of alcohol-related life events was found between men and women, however, men experienced alcohol dependence symptoms at a younger age and women had a more rapid clinical course. Women were found to have a higher heritability estimate for alcohol dependence (h(2)= .46) than men (h(2)= .32). These findings suggest that environmental factors influencing the initiation of regular drinking rather than genetic factors associated with dependence may in part underlie some of the gender differences seen in the prevalence of alcohol dependence in this population. (Am J Addict 2010;00:1-10).
Collapse
Affiliation(s)
- Cindy L Ehlers
- Department of Molecular and Integrative Neurosciences, The Scripps Research Institute, La Jolla, California, USA.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Hansell NK, Agrawal A, Whitfield JB, Morley KI, Gordon SD, Lind PA, Pergadia ML, Montgomery GW, Madden PAF, Todd RD, Heath AC, Martin NG. Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes? Alcohol Clin Exp Res 2009; 33:729-39. [PMID: 19183129 PMCID: PMC3164813 DOI: 10.1111/j.1530-0277.2008.00890.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Previous studies have identified evidence of genetic influence on alcohol use in samples selected to be informative for alcoholism research. However, there are a growing number of genome-wide association studies (GWAS) using samples unselected for alcohol consumption (i.e., selected on other traits and forms of psychopathology), which nevertheless assess consumption as a risk factor. Is it reasonable to expect that genes contributing to variation in alcohol consumption can be identified in such samples? METHODS An exploratory approach was taken to determine whether linkage analyses for heaviness of alcohol consumption, using a sample collected for heterogeneous purposes, could replicate previous findings. Quantity and frequency measures of consumption were collected in telephone interviews from community samples. These measures, and genotyping, were available for 5,441 individuals (5,067 quasi-independent sibling pairs). For 1,533 of these individuals, data were collected on 2 occasions, about 8.2 years apart, providing 2 datasets that maximize data collected at either a younger or an older age. Analyses were conducted to address the question of whether age and heavier levels of alcohol consumption effects outcome. Linkage results were compared in the younger and older full samples, and with samples in which approximately 10, 20, and 40 of drinkers from the lower end of the distribution of alcohol consumption were dropped. RESULTS Linkage peaks varied for the age differentiated samples and for percentage of light drinkers retained. Larger peaks (LOD scores >2.0) were typically found in regions previously identified in linkage studies and/or containing proposed candidate genes for alcoholism including AGT, CARTPT, OPRD1, PIK3R1, and PDYN. CONCLUSIONS The results suggest that GWAS assessing alcohol consumption as a covariate for other conditions will have some success in identifying genes contributing to consumption-related variation. However, sample characteristics, such as participant age, and trait distribution, may have substantial effects on the strength of the genetic signal. These results can inform forthcoming GWAS where the same restrictions apply.
Collapse
Affiliation(s)
- Narelle K Hansell
- Genetic Epidemiology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Malouff JM, Rooke SE, Schutte NS. The Heritability of Human Behavior: Results of Aggregating Meta-Analyses. CURRENT PSYCHOLOGY 2008. [DOI: 10.1007/s12144-008-9032-z] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
|
23
|
Zucker RA. Anticipating problem alcohol use developmentally from childhood into middle adulthood: what have we learned? Addiction 2008; 103 Suppl 1:100-8. [PMID: 18426543 PMCID: PMC2593849 DOI: 10.1111/j.1360-0443.2008.02179.x] [Citation(s) in RCA: 127] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
This commentary reviews and comments on six major longitudinal studies from the United States, Great Britain and Finland, that test predictive models of drinking and problem drinking behavior across a developmental span of one to two generations. The large Ns, in two instances involving population samples, and the broad and study-overlapping variable domains make this collection of studies unique and of special interest vis-à-vis the issue of cross-study replicability of findings. Significant cross-study commonalities are noted, involving the strong cross-study replicability of an undercontrol/externalizing domain as both a childhood and adolescent predictor of problem drinking outcomes in early to middle adulthood, the relative autostability of heavy and problem use of alcohol over intervals of time as long as a generation, the utility of early drinking behavior as an index for later drinking outcomes, the relative parallelism (with some exceptions) of male and female findings, albeit with greater predictability of male over female drinking outcomes and the relatively tighter relational networks of drinking and other behavioral characteristics for males. This impressive group of quasi-replications also points the field to address several next-step questions, including: (i) the need to parse the undercontrol/externalizing domain to identify those subcomponential process characteristics that are causal to heavy and problem drinking outcomes; (ii) the need to develop models that will handle more effectively the uneven relationships of negative activity to drinking outcomes, in some instances operating protectively, in other instances operating as risk factors; (iii) the need for more carefully articulated, theoretically driven process models that will specify the ordering, developmental saliency and mediational properties of risk and protective factors as they come on line; and (iv) the need for more developmental testing of trait/context interaction models of problem drinking development.
Collapse
Affiliation(s)
- Robert A. Zucker
- Department of Psychiatry and Addiction Research Center, University of Michigan
| |
Collapse
|
24
|
Hashimoto JG, Wiren KM. Neurotoxic consequences of chronic alcohol withdrawal: expression profiling reveals importance of gender over withdrawal severity. Neuropsychopharmacology 2008; 33:1084-96. [PMID: 17593928 PMCID: PMC3019135 DOI: 10.1038/sj.npp.1301494] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
While women are more vulnerable than men to many of the medical consequences of alcohol abuse, the role of sex in the response to ethanol is controversial. Neuroadaptive responses that result in the hyperexcitability associated with withdrawal from chronic ethanol likely reflect gene expression changes. We have examined both genders for the effects of withdrawal on brain gene expression using mice with divergent withdrawal severity that have been selectively bred from a genetically heterogeneous population. A total of 295 genes were identified as ethanol regulated from each gender of each selected line by microarray analyses. Hierarchical cluster analysis of the arrays revealed that the transcriptional response correlated with sex rather than with the selected withdrawal phenotype. Consistent with this, gene ontology category over-representation analysis identified cell death and DNA/RNA binding as targeted classes of genes in females, while in males, protein degradation, and calcium ion binding pathways were more altered by alcohol. Examination of ethanol-regulated genes and these distinct signaling pathways suggested enhanced neurotoxicity in females. Histopathological analysis of brain damage following ethanol withdrawal confirmed elevated cell death in female but not male mice. The sexually dimorphic response was observed irrespective of withdrawal phenotype. Combined, these results indicate a fundamentally distinct neuroadaptive response in females compared to males during chronic ethanol withdrawal and are consistent with observations that female alcoholics may be more vulnerable than males to ethanol-induced brain damage associated with alcohol abuse.
Collapse
Affiliation(s)
- Joel G Hashimoto
- Research Service, Veterans Affairs Medical Center, Oregon Health and Science University, Portland, OR, USA
- Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, USA
| | - Kristine M Wiren
- Research Service, Veterans Affairs Medical Center, Oregon Health and Science University, Portland, OR, USA
- Department of Behavioral Neuroscience, Oregon Health and Science University, Portland, OR, USA
- Department of Medicine, Oregon Health and Science University, Portland, OR, USA
- Correspondence: Dr KM Wiren, OHSU, Portland VA Medical Center, Research Service, P3 R&D39, Portland, OR 97239, USA, Tel: 503 220 8262, ext. 56595, Fax: 503 273 5351,
| |
Collapse
|
25
|
Underwood MD, Mann JJ, Huang YY, Arango V. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex. Alcohol Clin Exp Res 2008; 32:593-9. [PMID: 18241316 DOI: 10.1111/j.1530-0277.2007.00610.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND 5-Hydroxytryptophan (5-HT(2A)) receptor involvement in alcoholism is suggested by less 5-HT(2A) binding in alcohol preferring rats, association of a 5-HT(2A) receptor gene polymorphism with alcohol dependence and reduced alcohol intake with 5-HT(2A) antagonists. We sought to determine postmortem whether 5-HT(2A) receptors are altered in the prefrontal cortex (PFC) of alcoholics. METHODS Brain tissue from 25 alcoholics and 19 controls was collected at autopsy. Diagnosis of DSM-IV alcoholism/abuse and other psychiatric disorders and the determination of family history of alcoholism were made by psychological autopsy. Specific binding to 5-HT(2A) ((3)H-ketanserin) receptors in the PFC was measured by quantitative autoradiography. RESULTS 5-HT(2A) binding decreased with age [Brodmann areas (BA) 9, 46 gyrus; r = -0.381, -0.334, p < 0.05]. No differences in receptor binding between alcoholics and controls were detected in the gyrus or sulcus of any PFC area examined. Cases (controls or alcoholics) with a family history of alcoholism (n = 23) had less 5-HT(2A) binding throughout PFC than subjects without (n = 21) a family history of alcoholism (p < 0.05). 5-HT(2A) receptor binding in alcoholics without a family history of alcoholism (n = 7) did not differ from controls without a family history of alcoholism (n = 14). There was no association between alcoholism or alcohol rating and genotype. There was an association between genotype and the total amount of (3)H-ketanserin binding in BA46 with the TT genotype having more binding (TT>TC approximately CC). CONCLUSIONS Lower 5-HT(2A) receptor binding in the PFC of cases with a family history of alcoholism suggests a genetic predisposition to alcoholism. Alcohol abuse by itself did not have a significant effect on PFC 5-HT(2A) binding and as 5-HT(2A) binding in alcoholics is not different from controls and antagonists may be therapeutic, fewer receptors may result in downstream developmental effects on the brain resulting in a predisposition to alcoholism.
Collapse
Affiliation(s)
- Mark D Underwood
- Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, New York 10032, USA.
| | | | | | | |
Collapse
|
26
|
Hicks BM, Blonigen DM, Kramer MD, Krueger RF, Patrick CJ, Iacono WG, McGue M. Gender differences and developmental change in externalizing disorders from late adolescence to early adulthood: A longitudinal twin study. JOURNAL OF ABNORMAL PSYCHOLOGY 2007; 116:433-47. [PMID: 17696699 PMCID: PMC2242627 DOI: 10.1037/0021-843x.116.3.433] [Citation(s) in RCA: 155] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Using data from over 1,000 male and female twins participating in the Minnesota Twin Family Study, the authors examined developmental change, gender differences, and genetic and environmental contributions to the symptom levels of four externalizing disorders (adult antisocial behavior, alcohol dependence, nicotine dependence, and drug dependence) from ages 17 to 24. Both men and women increased in symptoms for each externalizing disorder, with men increasing at a greater rate than women, such that a modest gender gap at age 17 widened to a large one at age 24. Additionally, a mean-level gender difference on a latent Externalizing factor could account for the mean-level gender differences for the individual disorders. Biometric analyses revealed increasing genetic variation and heritability for men but a trend toward decreasing genetic variation and increasing environmental effects for women. Results illustrate the importance of gender and developmental context for symptom expression and the utility of structural models to integrate general trends and disorder-specific characteristics.
Collapse
Affiliation(s)
- Brian M Hicks
- University of Minnesota, Department of Psychology, Minneapolis, MN 55455, USA.
| | | | | | | | | | | | | |
Collapse
|
27
|
Ducci F, Enoch MA, Funt S, Virkkunen M, Albaugh B, Goldman D. Increased anxiety and other similarities in temperament of alcoholics with and without antisocial personality disorder across three diverse populations. Alcohol 2007; 41:3-12. [PMID: 17452294 PMCID: PMC1924490 DOI: 10.1016/j.alcohol.2007.02.005] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2006] [Revised: 02/14/2007] [Accepted: 02/14/2007] [Indexed: 10/23/2022]
Abstract
According to Cloninger's model, type I alcoholics are thought to be innately vulnerable to anxiety and depression. In contrast, type II alcoholics are thought to have increased likelihood of antisocial personality disorder (ASPD) and reduced anxiety. However, allostatic activations of stress, anxiety, and dysphoria may be a common thread in alcohol use disorders (AUDs). Our aim was to find commonalities and differences in temperament of alcoholics with and without ASPD in three diverse populations. By sib-sib comparisons, we also evaluated the extent to which the temperament traits were moderated by familial factors including inheritance. We compared harm avoidance (HA), novelty seeking (NS), and reward dependence (RD) in alcoholics with ASPD, alcoholics without ASPD, and controls. Correlations for each temperament dimension were evaluated in pairs of siblings concordant and discordant for AUD. Participants were derived from three independent populations: Finnish Caucasians (N=453, men=100%, including a sample of alcoholic criminals), a Plains American Indian community sample (N=378; men=42%), and a subset of the familial and predominantly Caucasian Collaborative Study on the Genetics of Alcoholism (COGA) sample (N=967, men=47%). In all the three populations, both alcoholics with and without ASPD were higher in HA than controls. The increase of HA among alcoholics as compared to controls ranged from 54% to 12%. In two populations (COGA and Finns), NS was highest in alcoholics with ASPD, intermediate in alcoholics without ASPD, and lowest in controls. HA levels were correlated in sib-pairs concordant (either affected or unaffected) for AUD but not in discordant pairs. In conclusions, despite cultural diversity and different modes of ascertainment we found a consistent pattern of elevated HA in all groups of alcoholics, including alcoholics with ASPD. Even in alcoholics with long-term exposure to the anxiogenic effects of repeated cycles of alcohol withdrawal, genetic and other familial influences seem to play a role in moderating anxiety.
Collapse
Affiliation(s)
- Francesca Ducci
- Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, 5625 Fishers Lane, Room 3S32, MSC 9412, Bethesda, MD 20892, USA.
| | | | | | | | | | | |
Collapse
|
28
|
Halder SLS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil 2006; 18:1001-8. [PMID: 17040411 DOI: 10.1111/j.1365-2982.2006.00815.x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The role of alcohol use in irritable bowel syndrome (IBS) and dyspepsia is not well understood. We hypothesised that people with psychological distress who drink no alcohol, or excess alcohol, are at increased risk of having IBS or dyspepsia. Valid gastrointestinal (GI) symptom surveys were mailed to randomly selected cohorts of community residents. Associations between IBS, dyspepsia and abdominal pain and alcohol use were assessed using logistic regression adjusted for a Somatic Symptom Checklist score (SSC). A total of 4390 (80%) responded; of these, 10.5% reported IBS, 2% dyspepsia and 22% abdominal pain. Alcohol consumption >7 drinks week(-1) was associated with a greater odds for dyspepsia (OR 2.3; 95% CI:1.1-5.0) and frequent abdominal pain (OR 1.5; 95% CI: 1.1-2.0) but not IBS. However, significant interactions among gender, alcohol use and SSC scores were detected (P < 0.005). In females with a low SSC score, consuming alcohol > or =7 drinks week(-1) increased the odds of IBS compared to drinking alcohol moderately. Alcohol consumption was associated with dyspepsia and abdominal pain. A relationship with IBS was identified when interactions with somatization and gender were appropriately considered. Whether these associations are due to the effects of alcohol on the gut, or a common central mechanism remains to be determined.
Collapse
Affiliation(s)
- S L S Halder
- Department of Gastroenterology, Hope Hospital, University of Manchester, Manchester, UK
| | | | | | | | | |
Collapse
|
29
|
Kuo PH, Neale MC, Riley BP, Webb BT, Sullivan PF, Vittum J, Patterson DG, Thiselton DL, van den Oord EJ, Walsh D, Kendler KS, Prescott CA. Identification of Susceptibility Loci for Alcohol-Related Traits in the Irish Affected Sib Pair Study of Alcohol Dependence. Alcohol Clin Exp Res 2006; 30:1807-16. [PMID: 17067344 DOI: 10.1111/j.1530-0277.2006.00217.x] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Alcoholism is a phenotypically and probably genetically heterogeneous condition. Thus, one strategy for finding genes influencing liability to alcoholism is to study the components of alcoholism, which may be more directly related to the underlying pathophysiology than is clinical diagnosis. The goal of this study was to identify genomic regions containing susceptibility loci for alcohol-related traits. METHODS A 4-cM dense whole-genome linkage study was conducted in the Irish Affected Sib Pair Study of Alcohol Dependence. Probands, affected siblings, and parents were evaluated by structured interview. Variance component linkage analysis was applied to data from 485 families for 5 measures: initial sensitivity and tolerance (based on scales from the self-report of the effects of ethanol; maximum drinks within 24 hours, an empirically derived factor score based on withdrawal symptoms, and age at onset of alcohol dependence. RESULTS Evidence for linkage (p<0.005) was found on 9 chromosomes. For age at onset, 2 regions were found on chromosome 9 (highest Lod=2.3, p=0.0005). For initial level of response to alcohol, suggestive regions were on chromosomes 1 and 11 (highest Lod=2.9, p=0.0001 on chromosome 11), while those for tolerance signals were on chromosomes 1, 6, and 22. Maximum drinking was associated with regions on chromosomes 12 and 18. For withdrawal symptoms, the highest peak was on chromosome 2 (Lod=2.2, p=0.0007). CONCLUSIONS Using quantitative measures of components of alcohol dependence, we identified several regions of the genome that may contain susceptibility loci for specific alcohol-related traits and merit additional study.
Collapse
Affiliation(s)
- Po-Hsiu Kuo
- Virginia Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA 23298, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Prescott CA, Madden PAF, Stallings MC. Challenges in genetic studies of the etiology of substance use and substance use disorders: introduction to the special issue. Behav Genet 2006; 36:473-82. [PMID: 16710779 DOI: 10.1007/s10519-006-9072-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2006] [Accepted: 03/14/2006] [Indexed: 10/24/2022]
Abstract
Misuse of psychoactive substances is associated with substantial costs to users and to society. A growing literature suggests individual differences in vulnerability to develop substance related problems are influenced to a large degree by genetic factors. We review the evidence from genetic epidemiologic and molecular genetic studies of problematic use of alcohol, tobacco, and other drugs, then discuss the challenges for the next generation of studies of genetic influences on substance use. These challenges are addressed in the remaining papers of this special issue. The papers cover a variety of approaches, substances, and non-human as well as human studies, but are united by their focus on going beyond heritability estimates to address the mechanisms and processes underlying the development of substance use and substance related problems, including measurement, precursors of substance abuse, stages of substance involvement, and specificity of genetic influences.
Collapse
Affiliation(s)
- Carol A Prescott
- Department of Psychology, University of Southern California, SGM 501, Los Angeles, CA, 90036, USA.
| | | | | |
Collapse
|
31
|
Abstract
PURPOSE OF REVIEW Alcohol dependence is a complex disorder with a well documented highly hereditary nature. This article reviews the recent advances in our understanding of the direct and indirect genetic influences on alcohol use and dependence. RECENT FINDINGS Recent findings can be summarized as follows: (a) twin studies have defined and estimated the risks of general and specific alcohol-related vulnerabilities. (b) Linkage studies have provided largely inconsistent findings, though several chromosomal regions have been implicated. (c) Quantitative trait loci analyses in animals have identified that the Mpdz gene predisposes to alcohol dependence and withdrawal. (d) Examination of family-based samples has identified several genes including GABRA2 and CHRM2 thought to be associated with alcohol dependence. SUMMARY Despite great advances in understanding of genetic vulnerability in alcohol use disorders, only two gene complexes, ADH and ALDH2, have been identified as having defined effects on alcohol use and liability to dependence in humans. New genes associated with increased risks for the disorder will certainly be added to this list in the near future. Neurobiological analyses of the effects of these genes will surely contribute to further understanding of the cause of alcohol dependence and the interindividual differences in risks.
Collapse
Affiliation(s)
- Susumu Higuchi
- National Hospital Organization, Kurihama Alcoholism Center, Yokosuka, Kanagawa, Japan.
| | | | | |
Collapse
|
32
|
Lemire M. A simple nonparametric multipoint procedure to test for linkage through mothers or fathers as well as imprinting effects in the presence of linkage. BMC Genet 2005; 6 Suppl 1:S159. [PMID: 16451620 PMCID: PMC1866775 DOI: 10.1186/1471-2156-6-s1-s159] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
A simple multipoint procedure to test for parent-of-origin effects in samples of affected siblings is discussed. The procedure consists of artificially changing all full sibs to half-sibs, with distinct mothers or fathers depending on the parental origin to be evaluated, then analyzing these families with commonly used statistics and software. The procedure leads to tests for linkage through mothers or fathers and also leads to a test for imprinting effects in the presence of linkage. Moreover, simulations illustrate that in regions unlinked to susceptibility genes this multipoint procedure does not have an inflated type I error if a sex-averaged genetic map is used, even when large differences exist between male-specific and female-specific maps. In regions linked with susceptibility genes, the test of imprinting is biased under the null hypothesis if differences exist between sex-specific maps, irrespective of the map used in the analysis. The procedure is applied to the Collaborative Study on the Genetics of Alcoholism dataset from the Genetic Analysis Workshop 14. Results indicate that brothers categorized as affected according to the DMS-III-R and Feighner classification show evidence of linkage through fathers to the 6q25 region (p = 0.00038) as well as modest evidence of imprinting (p = 0.018). This region harbors OPRM1, a candidate gene for substance dependence.
Collapse
Affiliation(s)
- Mathieu Lemire
- McGill University and Genome Quebec Innovation Centre, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
| |
Collapse
|